Mateus m bergamaschi (5 risultati)
- Altre immagini
- Brossura
Da: preigu, Osnabrück, Germaniapreigu
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 44,05
EUR 70,00 spedizioneSpedito da Germania a U.S.A.Quantità: 5 disponibili
Taschenbuch. Condizione: Neu. The anxiolytic effects and excretion of cannabinoids in humans | Mateus M. Bergamaschi | Taschenbuch | 140 S. | Englisch | 2019 | LAP LAMBERT Academic Publishing | EAN 9786139918294 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[do…t]de | Anbieter: preigu.
- Altre immagini
- Brossura
- Print on Demand
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermaniaBuchWeltWeit Ludwig Meier e.K.
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 49,90
EUR 23,00 spedizioneSpedito da Germania a U.S.A.Quantità: 2 disponibili
Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This study is divided into three parts. The first part aimed to investigate the cannabidiol anxiolytic effect in treatment-naïve individuals with social anxiety disorder through simulation of public speaking. The second part evalua…ted healthy subjects' anxiety during a public speaking test following a high rimonabant oral dose, to understand better the possible pharmacological approaches for anxiety disorder treatment. Finally, the third part aimed to monitor cannabinoid blood concentrations during sustained abstinence from chronic daily cannabis smoking. These findings can extend our knowledge on medical use of cannabinoids and impact development of per se laws to reduce morbidity and mortality from cannabis-impaired driving. 140 pp. Englisch.
- Altre immagini
- Brossura
- Print on Demand
Da: moluna, Greven, Germaniamoluna
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 41,71
EUR 48,99 spedizioneSpedito da Germania a U.S.A.Quantità: Più di 20 disponibili
Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Bergamaschi Mateus M.Mateus M. Bergamaschi completed his PhD in toxicology with honors from the University of Sao Paulo, Brazil in 2012. His research, conducted at the University of Sao Paulo and the N…ational Institute on Drug Abuse .
- Altre immagini
- Brossura
- Print on Demand
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germaniabuchversandmimpf2000
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 49,90
EUR 60,00 spedizioneSpedito da Germania a U.S.A.Quantità: 1 disponibili
Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This study is divided into three parts. The first part aimed to investigate the cannabidiol anxiolytic effect in treatment-naïve individuals with social anxiety disorder through simulation of public speaking. The second part evaluated…healthy subjects' anxiety during a public speaking test following a high rimonabant oral dose, to understand better the possible pharmacological approaches for anxiety disorder treatment. Finally, the third part aimed to monitor cannabinoid blood concentrations during sustained abstinence from chronic daily cannabis smoking. These findings can extend our knowledge on medical use of cannabinoids and impact development of per se laws to reduce morbidity and mortality from cannabis-impaired driving.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 140 pp. Englisch.
- Altre immagini
- Brossura
- Print on Demand
Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 50,50
EUR 61,14 spedizioneSpedito da Germania a U.S.A.Quantità: 1 disponibili
Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - This study is divided into three parts. The first part aimed to investigate the cannabidiol anxiolytic effect in treatment-naïve individuals with social anxiety disorder through simulation of public speaking. The second part evaluated h…ealthy subjects' anxiety during a public speaking test following a high rimonabant oral dose, to understand better the possible pharmacological approaches for anxiety disorder treatment. Finally, the third part aimed to monitor cannabinoid blood concentrations during sustained abstinence from chronic daily cannabis smoking. These findings can extend our knowledge on medical use of cannabinoids and impact development of per se laws to reduce morbidity and mortality from cannabis-impaired driving.
